Implantable biomaterials having engineered functional surfaces

US10034967B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10034967-B2
Application numberUS-201615219133-A
CountryUS
Kind codeB2
Filing dateJul 25, 2016
Priority dateSep 26, 2002
Publication dateJul 31, 2018
Grant dateJul 31, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Implantable materials having defined patterns of affinity regions for binding endothelial cells and providing for directed endothelial cell migration across the surface of the material. The affinity regions include photochemically altered regions of a material surface and physical members patterned on the material surface that exhibit a greater affinity for endothelial cell binding and migration than the remaining regions of the material surface.

First claim

Opening claim text (preview).

What is claimed is: 1. An implantable biomaterial having at least one surface thereof that comprises the biomaterial and a defined pattern of a plurality of functional features having a height above the at least one surface greater than 0μ, each of the plurality of functional features having a greater endothelial cell binding affinity greater than an endothelial cell binding affinity of the biomaterial. 2. The implantable biomaterial according to claim 1 , wherein each of the plurality of functional features further comprises a titanium oxide layer. 3. The implantable biomaterial according to claim 1 , wherein the biomaterial is made of a material that comprises a nickel-titanium alloy. 4. The implantable biomaterial according to claim 1 , wherein each of the plurality of functional features is made of a material that comprises carbon. 5. The implantable biomaterial according to claim 1 , wherein the functional features have a height between greater than 0μ to about 3.0μ. 6. The implantable biomaterial according to claim 1 , wherein each of the functional features comprises a focal adhesion point for affinity binding of endothelial cells. 7. The implantable biomaterial according to claim 1 , wherein each of the functional features has a width between about 10 μm to about 75 μm. 8. The implantable biomaterial according to claim 1 , further comprising a gap distance between adjacent functional features between about 10 μm to about 75 μm.

Assignees

Inventors

Classifications

  • Prostheses implantable into the body · CPC title

  • Coating made of titanium oxide or hydroxides · CPC title

  • A61F2/00Primary

    Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (dental prostheses A61C13/00; artificial kidneys A61M1/14; artificial hearts A61M60/00) · CPC title

  • Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence) · CPC title

  • for preferentially controlling or promoting the growth of specific types of cells or tissues · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10034967B2 cover?
Implantable materials having defined patterns of affinity regions for binding endothelial cells and providing for directed endothelial cell migration across the surface of the material. The affinity regions include photochemically altered regions of a material surface and physical members patterned on the material surface that exhibit a greater affinity for endothelial cell binding and migratio…
Who is the assignee on this patent?
Advanced Bio Prosthetic Surfaces Ltd, Vactronix Scientific Llc
What technology area does this patent fall under?
Primary CPC classification A61F2/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).